PROPOXYPHENE - ANVISA Registration 10287410677
Access comprehensive regulatory information for PROPOXYPHENE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287410677 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 2 similar products found using AI-powered semantic search, 4 companies making the same product including ROCHE DIAGNOSTICS GMBH (MANNHEIM), SIEMENS HEALTHACARE DIAGNOSTICS INC, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10287410677
25351613363200735
30280358000186
Company Information
Dates and Status
Feb 06, 2008
VIGENTE
09/18/2025 19:00:01
PROPOXIFENO
Alinity c Propoxyphene Reagent Kit
MICROGENICS CORPORATION
80146502323
Dec 17, 2020
PROPOXIFENO
PPX (ONLINE DAT Propoxyphene Plus)_cobas c
ROCHE DIAGNOSTICS GMBH (MANNHEIM)
10287411517
Jul 20, 2020
PROPOXIFENO
FAST TEST PPX
GUANGZHOU WONDFO BIOTECH CO., LTD.
80258020089
Jan 14, 2019
PROPOXIFENO
Atellica CH Propoxifeno (Ppx)
SIEMENS HEALTHACARE DIAGNOSTICS INC
10345162145
Dec 18, 2017